88m3
Fast Money & Foreign Objects
Hasn't he diverted or cut funding to the CDC?
Yes.
Hasn't he diverted or cut funding to the CDC?
At the rate the virus is propogating it might very well be a worst case scenario....60 percent of the global population could get infected... and to be frankly honest as a species we've had this coming for a long ass time.
Wellllllll.........
Pandemics do happen and have happened incrementally throughout human history, absolutely yes...........
But the origins of this pandemic.......??????
As of this very moment, nobody knows with 100% accuracy the origins of this virus. People, especially scientist, are saying it's a lot of questionable genetic attributes of this virus.
So my point is, when you say we have had this coming ........ are you considering the possibility, this is not just some natural mutation, but was very possibly genetically modified in a lab, and either escaped by accident or even more disturbing, purposefully put into the environment?
it is literally man made. what do you expect when you illegally trade in animals and cage them up in the most inhumane conditions? Do you actually have conclusive proof it's genetically modified. Youre one of those individuals who does not immediatelly default to truth, you're definitely needed but not everything in life of which you have no control over is a conspiracy theory
hopefully. the olympics has become a crime against humanityWonder if the Olympics will be affected by this.
Cotdamn brehs....some of yall jokers listen to mainstream media all day and think that shiit isn't filtered to the bone gristle.
Read.Lab-Made Coronavirus Triggers Debate
Lab-Made Coronavirus Triggers Debate
The creation of a chimeric SARS-like virus has scientists discussing the risks of gain-of-function research.
Jef Akst
Nov 16, 2015
MERS coronavirus
FLICKR, NIAID
Ralph Baric, an infectious-disease researcher at the University of North Carolina at Chapel Hill, last week (November 9) published a study on his team’s efforts to engineer a virus with the surface protein of the SHC014 coronavirus, found in horseshoe bats in China, and the backbone of one that causes human-like severe acute respiratory syndrome (SARS) in mice. The hybrid virus could infect human airway cells and caused disease in mice, according to the team’s results, which were published in Nature Medicine.
The results demonstrate the ability of the SHC014 surface protein to bind and infect human cells, validating concerns that this virus—or other coronaviruses found in bat species—may be capable of making the leap to people without first evolving in an intermediate host, Nature reported. They also reignite a debate about whether that information justifies the risk of such work, known as gain-of-function research. “If the [new] virus escaped, nobody could predict the trajectory,” Simon Wain-Hobson, a virologist at the Pasteur Institute in Paris, told Nature.
In October 2013, the US government put a stop to all federal funding for gain-of-function studies, with particular concern rising about influenza, SARS, and Middle East respiratory syndrome (MERS). “NIH [National Institutes of Health] has funded such studies because they help define the fundamental nature of human-pathogen interactions, enable the assessment of the pandemic potential of emerging infectious agents, and inform public health and preparedness efforts,” NIH Director Francis Collins said in a statement at the time. “These studies, however, also entail biosafety and biosecurity risks, which need to be understood better.”
Baric’s study on the SHC014-chimeric coronavirus began before the moratorium was announced, and the NIH allowed it to proceed during a review process, which eventually led to the conclusion that the work did not fall under the new restrictions, Baric told Nature. But some researchers, like Wain-Hobson, disagree with that decision.
The debate comes down to how informative the results are. “The only impact of this work is the creation, in a lab, of a new, non-natural risk,” Richard Ebright, a molecular biologist and biodefence expert at Rutgers University, told Nature.
But Baric and others argued the study’s importance. “[The results] move this virus from a candidate emerging pathogen to a clear and present danger,” Peter Daszak, president of the EcoHealth Alliance, which samples viruses from animals and people in emerging-diseases hotspots across the globe, told Nature.